DarioHealth (DRIO) vs Daxor (DXR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Daxor (DXR) has outperformed DarioHealth (DRIO) over the past year, losing 18.2% versus a loss of 63.0%. Over five years, DXR leads with a -7.5% price change compared with -98.2% for DRIO. Daxor is the larger company by market cap ($60.8 million vs $56.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DRIO | DXR |
|---|---|---|
| Share price | $5.80 | $10.41 |
| Market cap | $56.84M | $60.78M |
| 1-day change | +4.69% | -0.48% |
| YTD return | -49.03% | -29.42% |
| 1-year return | -63.03% | -18.22% |
| 5-year return | -98.21% | -7.47% |
| P/E ratio (TTM) | — | 9.55 |
| EPS (TTM) | $-2.39 | $1.09 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $16.50 | $14.76 |
| 52-week low | $5.37 | $8.56 |
| Distance from 52-week high | -64.85% | -29.47% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +134.48% | +92.12% |
| Average volume | 25.33K | 17.27K |
| Shares outstanding | 9.80M | 5.84M |
| Employees | 160 | — |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- DXR has outperformed DRIO by 44.8 percentage points over the past year.
About DarioHealth
DRIO stock →DarioHealth Corp. operates as a digital health company in the United States and internationally.
Health Care · Medical/Dental Instruments · 160 employees
About Daxor
DXR stock →Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit.
Health Care · Medical/Dental Instruments
DRIO vs DXR FAQ
Which is bigger, DarioHealth or Daxor?
Daxor (DXR) is larger, with a market capitalization of $60.78M compared with $56.84M for DarioHealth (DRIO).
Which stock has performed better over the past year, DRIO or DXR?
DXR returned -18.22% over the past 12 months, compared with -63.03% for DRIO (price return, excluding dividends). Past performance does not predict future results.
Are DarioHealth and Daxor in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.